Pitcairn CO Moderna, Inc. Transaction History

Pitcairn CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $150,934 - $267,801	1,275 New	1,275 $229,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $3,748 - $5,650	32 Added 2.32%	1,412 $202,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $36,799 - $68,399	-291 Reduced 17.41%	1,380 $238,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $257,660 - $420,469	-1,141 Reduced 40.58%	1,671 $424,000
Q3 2021 Nov 10, 2021	SELL	$221.9 - $484.47 $771,768 - $1.68 Million	-3,478 Reduced 55.29%	2,812 $1.08 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $234.98 $599,144 - $1.08 Million	4,612 Added 274.85%	6,290 $1.48 Million
Q1 2021 May 10, 2021	BUY	$109.18 - $185.98 $183,204 - $312,074	1,678 New	1,678 $219,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.